Lockley, M., Robinson, K., Miller, R., Gourley, C., Counsell, N., Mcneish, I., . . . Anderson, A. R. A. Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): A multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationLockley, Michelle, et al. Study Protocol for Adaptive ChemoTherapy for Ovarian Cancer (ACTOv): A Multicentre Phase II Randomised Controlled Trial to Evaluate the Efficacy of Adaptive Therapy (AT) with Carboplatin, Based on Changes in CA125, in Patients with Relapsed Platinum-sensitive High-grade Serous or High-grade Endometrioid Ovarian Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationLockley, Michelle, et al. Study Protocol for Adaptive ChemoTherapy for Ovarian Cancer (ACTOv): A Multicentre Phase II Randomised Controlled Trial to Evaluate the Efficacy of Adaptive Therapy (AT) with Carboplatin, Based on Changes in CA125, in Patients with Relapsed Platinum-sensitive High-grade Serous or High-grade Endometrioid Ovarian Cancer. BMJ Publishing Group.